https://www.selleckchem.com/products/pt2399.html
The secondary metabolites were screened, and 17 isolates were identified as promising antitumour compound producers. However, the bio-guided assay showed a pronounced antiproliferative activity for the crude extracts of Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653. The TGI and LC50 values revealed the potential of these natural products to control the proliferation of breast (MCF-7), glioblastoma (U251), lung/non-small (NCI-H46 and kidney (786- human cancer cell lines. Cinerubin B and actinomycin V were the predominant c
Like
Comment
Share
